Avidity Biosciences Announces Upcoming Presentations at 2023 MDA Clinical & Scientific Conference
/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...
San Diego United States Navjot Rai Kathleen Gallagher Avidity Biosciences Inc Development For The Treatment
Source: prnewswire.com